Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Catalys Pacific, LLC

Q1 2024 · 13F-HR

Catalys Pacific, LLCholdings as filed

Filed 2024-05-14 · accession 0001104659-24-060699

$148.1M
Reported value
3
Positions
2024-03-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
603170101MLYSMineralys Therapeutics, Inc.$118.7M80.1%9,194,579CommonSOLE
43157M102HilleVax , Inc.$21.8M14.7%1,308,974CommonSOLE
71722W107PHATPhathom Pharmaceuticals, Inc.$7.7M5.18%721,962CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.